世界のゲノム編集市場2021-2028:技術別(CRISPR、ZFN、TALEN)、送達方法別、用途別、モード別、最終用途別、地域別

◆英語タイトル:Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN, TALEN), By Delivery Method, By Application, By Mode, By End-use, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MY058
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年5月18日
◆ページ数:200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥654,500見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥764,500見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥984,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界のゲノム編集市場規模が2028年までに194億ドルに達すると予測しています。2021年から2028年までに年平均22.9%成長する見通しです。本市場調査資料では、ゲノム編集の世界市場について調査し、調査手法、エグゼクティブサマリー、産業見通し、技術別(CRISPR/Cas9、ALEN/MegaTAL、ZFN、メガヌクレアーゼ、その他)分析、送達方法別(Ex-vivo、In-vivo)分析、用途別(遺伝子エンジニアリング、臨床応用)分析、最終用途別(バイオテクノロジー&製薬会社、学術&政府研究機関、受託研究機関(CRO))分析、地域別分析、競争状況など、以下の構成でまとめております。
・調査手法
・エグゼクティブサマリー
・産業見通し
・世界のゲノム編集市場規模:技術別(CRISPR/Cas9、ALEN/MegaTAL、ZFN、メガヌクレアーゼ、その他)
・世界のゲノム編集市場規模:送達方法別(Ex-vivo、In-vivo)
・世界のゲノム編集市場規模:用途別(遺伝子エンジニアリング、臨床応用)
・世界のゲノム編集市場規模:最終用途別(バイオテクノロジー&製薬会社、学術&政府研究機関、受託研究機関(CRO))
・世界のゲノム編集市場規模:地域別
・競争状況
【レポートの概要】

Table of Contents

Chapter 1 Genome Editing Market: Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Market segmentation & scope
1.4 Market definition
1.5 Information procurement
1.5.1 Purchased database
1.5.2 GVR’s internal database
1.5.3 Secondary sources & Third-Party perspectives
1.5.4 Primary research
1.6 Information analysis
1.6.1 Data analysis models
1.7 Market formulation & data visualization
1.8 Data validation & publishing
Chapter 2 Genome Editing Market: Executive Summary
2.1 Genome Editing Market Outlook, 2017 – 2028
2.2 Segment Outlook
Chapter 3 Genome Editing Market: Industry Outlook
3.1 Market Pyramid Analysis
3.1.1 Parent Market
3.1.2 Ancillary Market
3.2 Market Dynamics Analysis
3.2.1 Market Driver Analysis
3.2.1.1 Success in pre-clinical models drives demands for genome editing therapeutics
3.2.1.2 Rising competition amongst market participants for business development
3.2.1.3 Easy editing solutions for the development of therapeutics for a broad range of diseases
3.2.1.4 Increasing demand for synthetic genes and genetically modified organisms
3.2.1.5 Technological advancements in gene editing technologies
3.2.1.6 Rising adoption in agricultural biotechnology
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges with respect to clinical translation
3.2.2.2 Regulatory, scientific, and ethical challenges pertaining to the use of genetically modified products
3.2.2.3 Off-target effects of CRISPR technology
3.3 Penetration &Growth Prospect MappingforTechnology, 2020
3.4 Genome editing -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis – Porter’s
3.6 Genome Editing Technologies: Pipeline Analysis
3.6.1 Sangamo
3.6.2 Cellectis
3.6.3 Calyxt
3.6.4 bluebird bio
3.6.5 Editas Medicine
3.6.6 Intellia Therapeutics, Inc.
3.6.7 CRISPR Therapeutics
3.6.8 Precision Biosciences
3.6.9 Precision Biosciences (Non-medical domain)
3.6.10 Caribou Biosciences
3.6.11 Cibus
3.6.12 Recombinetics, Inc
3.7 Intellectual Property
3.8 Regulatory Issues
3.8.1 Orphan diseases
3.8.2 Germline editing
3.8.3 Safety issues
3.9 COVID-19 Impact Analysis
Chapter 4 Genome Editing Market: Technology Business Analysis
4.1 Genome Editing Market: Technology Movement Analysis
4.2 Genome EditingTechnology Comparison
4.3 (CRISPR)/Cas9
4.3.1 Global (CRISPR)/Cas9 market, 2017 – 2028 (USD Million)
4.4 TALENs/MegaTALs
4.4.1 Global TALENs/MegaTALs market, 2017 – 2028 (USD Million)
4.5 ZFN
4.5.1 Global ZFN market, 2017 – 2028 (USD Million)
4.6 Meganucleases
4.6.1 Global Meganucleases market, 2017 – 2028 (USD Million)
4.7 Other Technologies
4.7.1 Global other technologies market, 2017 – 2028 (USD Million)
Chapter 5 Genome Editing Market: Delivery Method Business Analysis
5.1 Genome Editing Market: Delivery Method Movement Analysis
5.1.1 Comparison of Delivery Methods
5.1.1.1 Viral delivery
5.1.1.1.1 AAV (Adeno Associated Virus)
5.1.1.1.2 IDLV (Integrase Deficient Lentivirus).
5.1.1.2 Non-viral delivery
5.1.1.2.1 Lipid Mediated
5.1.1.2.2 Electroporation
5.2 Ex-vivo
5.2.1 Global ex-vivo delivery market, 2017 – 2028 (USD Million)
5.3 In-vivo
5.3.1 Global in-vivo delivery market, 2017 – 2028 (USD Million)
Chapter 6 Genome Editing Market: Application Business Analysis
6.1 Market: ApplicationMovement Analysis
6.2 Genetic Engineering
6.2.1 Market, 2017 – 2028 (USD Million)
6.2.1.1 Cell line engineering
6.2.1.1.1 Market, 2017 – 2028 (USD Million)
6.2.1.2 Animal genetic engineering
6.2.1.2.1 Market, 2017 – 2028 (USD Million)
6.2.1.3 Plant genetic engineering
6.2.1.3.1 Market, 2017 – 2028 (USD Million)
6.2.1.4 Others
6.2.1.4.1 Global others market, 2017 – 2028 (USD Million)
6.3 Clinical Applications
6.3.1 Market for clinical applications, 2017 – 2028 (USD Million)
6.3.1.1 Diagnostics
6.3.1.1.1 Market for diagnostics applications, 2017 – 2028 (USD Million)
6.3.1.2 Therapy Development
6.3.1.2.1 Market for therapy development applications, 2017 – 2028 (USD Million)
Chapter 7 Genome Editing Market: End-Use Business Analysis
7.1 Market: End-use Movement Analysis
7.2 Biotechnology & Pharmaceutical Companies
7.2.1 Market, 2017 – 2028 (USD Million)
7.3 Academic & Government Research Institutes
7.3.1 Market, 2017 – 2028 (USD Million)
7.4 Contract Research Organizations (CROs)
7.4.1 Market, 2017 – 2028 (USD Million)
Chapter 8 Genome Editing Market: Mode Business Analysis
8.1 Market: Mode Movement Analysis
8.2 In-house
8.2.1 Market, 2017 – 2028 (USD Million)
8.3 Contract
8.3.1 Market, 2017 – 2028 (USD Million)
Chapter 9 Genome Editing Market: Regional Business Analysis
9.1 Market Share By Region, 2020 & 2028
9.2 North America
9.2.1 Market, 2017 – 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. genome editing market, by technology, 2017 – 2028 (USD Million)
9.2.2.2 U.S. genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.2.2.3 U.S. genome editing market, by application, 2017 – 2028 (USD Million)
9.2.2.4 U.S. genome editing market, by end-use, 2017 – 2028 (USD Million)
9.2.2.5 U.S. genome editing market, by mode, 2017 – 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada genome editing market, by technology, 2017 – 2028 (USD Million)
9.2.3.2 Canada genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.2.3.3 Canada genome editing market, by application, 2017 – 2028 (USD Million)
9.2.3.4 Canada genome editing market, by end-use, 2017 – 2028 (USD Million)
9.2.3.5 Canada genome editing market, by mode, 2017 – 2028 (USD Million)
9.3 Europe
9.3.1 Europe genome editing market, 2017 – 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.3.2 Germany genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.3.3 Germany genome editing market, by application, 2017 – 2028 (USD Million)
9.3.3.4 Germany genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.3.5 Germany genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.3.2 U.K. genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.3.3 U.K. genome editing market, by application, 2017 – 2028 (USD Million)
9.3.3.4 U.K. genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.3.5 U.K. genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.4 Italy
9.3.4.1 Italy genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.4.2 Italy genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.4.3 Italy genome editing market, by application, 2017 – 2028 (USD Million)
9.3.4.4 Italy genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.4.5 Italy genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.5 France
9.3.5.1 France genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.5.2 France genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.5.3 France genome editing market, by application, 2017 – 2028 (USD Million)
9.3.5.4 France genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.5.5 France genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.6.2 Spain genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.6.3 Spain genome editing market, by application, 2017 – 2028 (USD Million)
9.3.6.4 Spain genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.6.5 Spain genome editing market, by mode, 2017 – 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific genome editing market, 2017 – 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.2.2 Japan genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.2.3 Japan genome editing market, by application, 2017 – 2028 (USD Million)
9.4.2.4 Japan genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.2.5 Japan genome editing market, by mode, 2017 – 2028 (USD Million)
9.4.3 China
9.4.3.1 China genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.3.2 China genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.3.3 China genome editing market, by application, 2017 – 2028 (USD Million)
9.4.3.4 China genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.3.5 China genome editing market, by mode, 2017 – 2028 (USD Million)
9.4.4 South Korea
9.4.4.1 South Korea genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.4.2 South Korea genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.4.3 South Korea genome editing market, by application, 2017 – 2028 (USD Million)
9.4.4.4 South Korea genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.4.5 South Korea genome editing market, by mode, 2017 – 2028 (USD Million)
9.4.5 India
9.4.5.1 India genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.5.2 India genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.5.3 India genome editing market, by application, 2017 – 2028 (USD Million)
9.4.5.4 India genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.5.5 India genome editing market, by mode, 2017 – 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America genome editing market, 2017 – 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil genome editing market, by technology, 2017 – 2028 (USD Million)
9.5.2.2 Brazil genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.5.2.3 Brazil genome editing market, by application, 2017 – 2028 (USD Million)
9.5.2.4 Brazil genome editing market, by end-use, 2017 – 2028 (USD Million)
9.5.2.5 Brazil genome editing market, by mode, 2017 – 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico genome editing market, by technology, 2017 – 2028 (USD Million)
9.5.3.2 Mexico genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.5.3.3 Mexico genome editing market, by application, 2017 – 2028 (USD Million)
9.5.3.4 Mexico genome editing market, by end-use, 2017 – 2028 (USD Million)
9.5.3.5 Mexico genome editing market, by mode, 2017 – 2028 (USD Million)
9.6 Middle East & Africa
9.6.1 Middle East & Africa genome editing market, 2017 – 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa genome editing market, by technology, 2017 – 2028 (USD Million)
9.6.2.2 South Africa genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.6.2.3 South Africa genome editing market, by application, 2017 – 2028 (USD Million)
9.6.2.4 South Africa genome editing market, by end-use, 2017 – 2028 (USD Million)
9.6.2.5 South Africa genome editing market, by mode, 2017 – 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia genome editing market, by technology, 2017 – 2028 (USD Million)
9.6.3.2 Saudi Arabia genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.6.3.3 Saudi Arabia genome editing market, by application, 2017 – 2028 (USD Million)
9.6.3.4 Saudi Arabia genome editing market, by end-use, 2017 – 2028 (USD Million)
9.6.3.5 Saudi Arabia genome editing market, by mode, 2017 – 2028 (USD Million)
Chapter 10 Genome Editing Market: Competitive Landscape
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Strategic Alliance Analysis
10.3.1 Mergers & Acquisitions
10.3.2 Technological Collaborations
10.3.3 Licensing and partnership
10.4 Recent Developments & Impact Analysis
10.5 List of Potential End-users
10.6 Company Profiles
10.6.1 Merck KGaA
10.6.1.1 Company overview
10.6.1.1.1 Sigma-Aldrich Co. LLC
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic initiatives
10.6.2 Cibus
10.6.2.1 Company overview
10.6.2.1.1 Nucelis
10.6.2.2 Financial performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic initiatives
10.6.3 Recombinetics, Inc
10.6.3.1 Company overview
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic initiatives
10.6.4 Sangamo
10.6.4.1 Company overview
10.6.4.2 Financial performance
10.6.4.3 Product benchmarking
10.6.4.4 Strategic initiatives
10.6.5 Editas Medicine
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic initiatives
10.6.6 Precision Biosciences
10.6.6.1 Company overview
10.6.6.2 Financial performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic initiatives
10.6.7 CRISPR THERAPEUTICS
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Intellia Therapeutics, Inc.
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 Caribou Biosciences, Inc
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives
10.6.10 Cellectis
10.6.10.1 Company overview
10.6.10.2 Financial performance
10.6.10.3 Product benchmarking
10.6.10.4 Strategic initiatives
10.6.11 AstraZeneca
10.6.11.1 Company overview
10.6.11.2 Financial performance
10.6.11.3 Product benchmarking
10.6.11.4 Strategic initiatives
10.6.12 Takara Bio Inc.
10.6.12.1 Company overview
10.6.12.2 Financial performance
10.6.12.3 Product benchmarking
10.6.12.4 Strategic initiatives
10.6.13 Horizon Discovery Group plc
10.6.13.1 Company overview
10.6.13.2 Financial performance
10.6.13.3 Product benchmarking
10.6.13.4 Strategic initiatives
10.6.14 Integrated DNA Technologies, Inc.
10.6.14.1 Company overview
10.6.14.2 Financial performance
10.6.14.3 Product benchmarking
10.6.15 Transposagen Biopharmaceuticals, Inc.
10.6.15.1 Company overview
10.6.15.2 Financial performance
10.6.15.3 Product benchmarking
10.6.16 GenScript
10.6.16.1 Company overview
10.6.16.2 Financial performance
10.6.16.3 Product benchmarking
10.6.16.4 Strategic initiatives
10.6.17 New England Biolabs
10.6.17.1 Company overview
10.6.17.2 Financial performance
10.6.17.3 Product benchmarking
10.6.17.4 Strategic initiatives
10.6.18 OriGene Technologies, Inc.
10.6.18.1 Company overview
10.6.18.2 Financial performance
10.6.18.3 Product benchmarking
10.6.18.4 Strategic initiatives
10.6.19 bluebird bio, Inc.
10.6.19.1 Company overview
10.6.19.2 Financial performance
10.6.19.3 Product benchmarking
10.6.19.4 Strategic initiatives
10.6.20 Lonza
10.6.20.1 Company overview
10.6.20.2 Financial performance
10.6.20.3 Product benchmarking
10.6.20.4 Strategic initiatives
10.6.21 Thermo Fisher Scientific, Inc.
10.6.21.1 Company overview
10.6.21.2 Financial performance
10.6.21.3 Product benchmarking
10.6.21.4 Strategic initiatives

【レポートの目次】

Table of Contents

Chapter 1 Genome Editing Market: Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Market segmentation & scope
1.4 Market definition
1.5 Information procurement
1.5.1 Purchased database
1.5.2 GVR’s internal database
1.5.3 Secondary sources & Third-Party perspectives
1.5.4 Primary research
1.6 Information analysis
1.6.1 Data analysis models
1.7 Market formulation & data visualization
1.8 Data validation & publishing
Chapter 2 Genome Editing Market: Executive Summary
2.1 Genome Editing Market Outlook, 2017 – 2028
2.2 Segment Outlook
Chapter 3 Genome Editing Market: Industry Outlook
3.1 Market Pyramid Analysis
3.1.1 Parent Market
3.1.2 Ancillary Market
3.2 Market Dynamics Analysis
3.2.1 Market Driver Analysis
3.2.1.1 Success in pre-clinical models drives demands for genome editing therapeutics
3.2.1.2 Rising competition amongst market participants for business development
3.2.1.3 Easy editing solutions for the development of therapeutics for a broad range of diseases
3.2.1.4 Increasing demand for synthetic genes and genetically modified organisms
3.2.1.5 Technological advancements in gene editing technologies
3.2.1.6 Rising adoption in agricultural biotechnology
3.2.2 Market Restraint Analysis
3.2.2.1 Challenges with respect to clinical translation
3.2.2.2 Regulatory, scientific, and ethical challenges pertaining to the use of genetically modified products
3.2.2.3 Off-target effects of CRISPR technology
3.3 Penetration &Growth Prospect MappingforTechnology, 2020
3.4 Genome editing -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis – Porter’s
3.6 Genome Editing Technologies: Pipeline Analysis
3.6.1 Sangamo
3.6.2 Cellectis
3.6.3 Calyxt
3.6.4 bluebird bio
3.6.5 Editas Medicine
3.6.6 Intellia Therapeutics, Inc.
3.6.7 CRISPR Therapeutics
3.6.8 Precision Biosciences
3.6.9 Precision Biosciences (Non-medical domain)
3.6.10 Caribou Biosciences
3.6.11 Cibus
3.6.12 Recombinetics, Inc
3.7 Intellectual Property
3.8 Regulatory Issues
3.8.1 Orphan diseases
3.8.2 Germline editing
3.8.3 Safety issues
3.9 COVID-19 Impact Analysis
Chapter 4 Genome Editing Market: Technology Business Analysis
4.1 Genome Editing Market: Technology Movement Analysis
4.2 Genome EditingTechnology Comparison
4.3 (CRISPR)/Cas9
4.3.1 Global (CRISPR)/Cas9 market, 2017 – 2028 (USD Million)
4.4 TALENs/MegaTALs
4.4.1 Global TALENs/MegaTALs market, 2017 – 2028 (USD Million)
4.5 ZFN
4.5.1 Global ZFN market, 2017 – 2028 (USD Million)
4.6 Meganucleases
4.6.1 Global Meganucleases market, 2017 – 2028 (USD Million)
4.7 Other Technologies
4.7.1 Global other technologies market, 2017 – 2028 (USD Million)
Chapter 5 Genome Editing Market: Delivery Method Business Analysis
5.1 Genome Editing Market: Delivery Method Movement Analysis
5.1.1 Comparison of Delivery Methods
5.1.1.1 Viral delivery
5.1.1.1.1 AAV (Adeno Associated Virus)
5.1.1.1.2 IDLV (Integrase Deficient Lentivirus).
5.1.1.2 Non-viral delivery
5.1.1.2.1 Lipid Mediated
5.1.1.2.2 Electroporation
5.2 Ex-vivo
5.2.1 Global ex-vivo delivery market, 2017 – 2028 (USD Million)
5.3 In-vivo
5.3.1 Global in-vivo delivery market, 2017 – 2028 (USD Million)
Chapter 6 Genome Editing Market: Application Business Analysis
6.1 Market: ApplicationMovement Analysis
6.2 Genetic Engineering
6.2.1 Market, 2017 – 2028 (USD Million)
6.2.1.1 Cell line engineering
6.2.1.1.1 Market, 2017 – 2028 (USD Million)
6.2.1.2 Animal genetic engineering
6.2.1.2.1 Market, 2017 – 2028 (USD Million)
6.2.1.3 Plant genetic engineering
6.2.1.3.1 Market, 2017 – 2028 (USD Million)
6.2.1.4 Others
6.2.1.4.1 Global others market, 2017 – 2028 (USD Million)
6.3 Clinical Applications
6.3.1 Market for clinical applications, 2017 – 2028 (USD Million)
6.3.1.1 Diagnostics
6.3.1.1.1 Market for diagnostics applications, 2017 – 2028 (USD Million)
6.3.1.2 Therapy Development
6.3.1.2.1 Market for therapy development applications, 2017 – 2028 (USD Million)
Chapter 7 Genome Editing Market: End-Use Business Analysis
7.1 Market: End-use Movement Analysis
7.2 Biotechnology & Pharmaceutical Companies
7.2.1 Market, 2017 – 2028 (USD Million)
7.3 Academic & Government Research Institutes
7.3.1 Market, 2017 – 2028 (USD Million)
7.4 Contract Research Organizations (CROs)
7.4.1 Market, 2017 – 2028 (USD Million)
Chapter 8 Genome Editing Market: Mode Business Analysis
8.1 Market: Mode Movement Analysis
8.2 In-house
8.2.1 Market, 2017 – 2028 (USD Million)
8.3 Contract
8.3.1 Market, 2017 – 2028 (USD Million)
Chapter 9 Genome Editing Market: Regional Business Analysis
9.1 Market Share By Region, 2020 & 2028
9.2 North America
9.2.1 Market, 2017 – 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. genome editing market, by technology, 2017 – 2028 (USD Million)
9.2.2.2 U.S. genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.2.2.3 U.S. genome editing market, by application, 2017 – 2028 (USD Million)
9.2.2.4 U.S. genome editing market, by end-use, 2017 – 2028 (USD Million)
9.2.2.5 U.S. genome editing market, by mode, 2017 – 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada genome editing market, by technology, 2017 – 2028 (USD Million)
9.2.3.2 Canada genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.2.3.3 Canada genome editing market, by application, 2017 – 2028 (USD Million)
9.2.3.4 Canada genome editing market, by end-use, 2017 – 2028 (USD Million)
9.2.3.5 Canada genome editing market, by mode, 2017 – 2028 (USD Million)
9.3 Europe
9.3.1 Europe genome editing market, 2017 – 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.3.2 Germany genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.3.3 Germany genome editing market, by application, 2017 – 2028 (USD Million)
9.3.3.4 Germany genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.3.5 Germany genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.3.2 U.K. genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.3.3 U.K. genome editing market, by application, 2017 – 2028 (USD Million)
9.3.3.4 U.K. genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.3.5 U.K. genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.4 Italy
9.3.4.1 Italy genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.4.2 Italy genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.4.3 Italy genome editing market, by application, 2017 – 2028 (USD Million)
9.3.4.4 Italy genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.4.5 Italy genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.5 France
9.3.5.1 France genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.5.2 France genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.5.3 France genome editing market, by application, 2017 – 2028 (USD Million)
9.3.5.4 France genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.5.5 France genome editing market, by mode, 2017 – 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain genome editing market, by technology, 2017 – 2028 (USD Million)
9.3.6.2 Spain genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.3.6.3 Spain genome editing market, by application, 2017 – 2028 (USD Million)
9.3.6.4 Spain genome editing market, by end-use, 2017 – 2028 (USD Million)
9.3.6.5 Spain genome editing market, by mode, 2017 – 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific genome editing market, 2017 – 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.2.2 Japan genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.2.3 Japan genome editing market, by application, 2017 – 2028 (USD Million)
9.4.2.4 Japan genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.2.5 Japan genome editing market, by mode, 2017 – 2028 (USD Million)
9.4.3 China
9.4.3.1 China genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.3.2 China genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.3.3 China genome editing market, by application, 2017 – 2028 (USD Million)
9.4.3.4 China genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.3.5 China genome editing market, by mode, 2017 – 2028 (USD Million)
9.4.4 South Korea
9.4.4.1 South Korea genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.4.2 South Korea genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.4.3 South Korea genome editing market, by application, 2017 – 2028 (USD Million)
9.4.4.4 South Korea genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.4.5 South Korea genome editing market, by mode, 2017 – 2028 (USD Million)
9.4.5 India
9.4.5.1 India genome editing market, by technology, 2017 – 2028 (USD Million)
9.4.5.2 India genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.4.5.3 India genome editing market, by application, 2017 – 2028 (USD Million)
9.4.5.4 India genome editing market, by end-use, 2017 – 2028 (USD Million)
9.4.5.5 India genome editing market, by mode, 2017 – 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America genome editing market, 2017 – 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil genome editing market, by technology, 2017 – 2028 (USD Million)
9.5.2.2 Brazil genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.5.2.3 Brazil genome editing market, by application, 2017 – 2028 (USD Million)
9.5.2.4 Brazil genome editing market, by end-use, 2017 – 2028 (USD Million)
9.5.2.5 Brazil genome editing market, by mode, 2017 – 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico genome editing market, by technology, 2017 – 2028 (USD Million)
9.5.3.2 Mexico genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.5.3.3 Mexico genome editing market, by application, 2017 – 2028 (USD Million)
9.5.3.4 Mexico genome editing market, by end-use, 2017 – 2028 (USD Million)
9.5.3.5 Mexico genome editing market, by mode, 2017 – 2028 (USD Million)
9.6 Middle East & Africa
9.6.1 Middle East & Africa genome editing market, 2017 – 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa genome editing market, by technology, 2017 – 2028 (USD Million)
9.6.2.2 South Africa genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.6.2.3 South Africa genome editing market, by application, 2017 – 2028 (USD Million)
9.6.2.4 South Africa genome editing market, by end-use, 2017 – 2028 (USD Million)
9.6.2.5 South Africa genome editing market, by mode, 2017 – 2028 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Saudi Arabia genome editing market, by technology, 2017 – 2028 (USD Million)
9.6.3.2 Saudi Arabia genome editing market, by delivery method, 2017 – 2028 (USD Million)
9.6.3.3 Saudi Arabia genome editing market, by application, 2017 – 2028 (USD Million)
9.6.3.4 Saudi Arabia genome editing market, by end-use, 2017 – 2028 (USD Million)
9.6.3.5 Saudi Arabia genome editing market, by mode, 2017 – 2028 (USD Million)
Chapter 10 Genome Editing Market: Competitive Landscape
10.1 Strategy Framework
10.2 Market Participation Categorization
10.3 Strategic Alliance Analysis
10.3.1 Mergers & Acquisitions
10.3.2 Technological Collaborations
10.3.3 Licensing and partnership
10.4 Recent Developments & Impact Analysis
10.5 List of Potential End-users
10.6 Company Profiles
10.6.1 Merck KGaA
10.6.1.1 Company overview
10.6.1.1.1 Sigma-Aldrich Co. LLC
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic initiatives
10.6.2 Cibus
10.6.2.1 Company overview
10.6.2.1.1 Nucelis
10.6.2.2 Financial performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic initiatives
10.6.3 Recombinetics, Inc
10.6.3.1 Company overview
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic initiatives
10.6.4 Sangamo
10.6.4.1 Company overview
10.6.4.2 Financial performance
10.6.4.3 Product benchmarking
10.6.4.4 Strategic initiatives
10.6.5 Editas Medicine
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic initiatives
10.6.6 Precision Biosciences
10.6.6.1 Company overview
10.6.6.2 Financial performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic initiatives
10.6.7 CRISPR THERAPEUTICS
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Intellia Therapeutics, Inc.
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 Caribou Biosciences, Inc
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives
10.6.10 Cellectis
10.6.10.1 Company overview
10.6.10.2 Financial performance
10.6.10.3 Product benchmarking
10.6.10.4 Strategic initiatives
10.6.11 AstraZeneca
10.6.11.1 Company overview
10.6.11.2 Financial performance
10.6.11.3 Product benchmarking
10.6.11.4 Strategic initiatives
10.6.12 Takara Bio Inc.
10.6.12.1 Company overview
10.6.12.2 Financial performance
10.6.12.3 Product benchmarking
10.6.12.4 Strategic initiatives
10.6.13 Horizon Discovery Group plc
10.6.13.1 Company overview
10.6.13.2 Financial performance
10.6.13.3 Product benchmarking
10.6.13.4 Strategic initiatives
10.6.14 Integrated DNA Technologies, Inc.
10.6.14.1 Company overview
10.6.14.2 Financial performance
10.6.14.3 Product benchmarking
10.6.15 Transposagen Biopharmaceuticals, Inc.
10.6.15.1 Company overview
10.6.15.2 Financial performance
10.6.15.3 Product benchmarking
10.6.16 GenScript
10.6.16.1 Company overview
10.6.16.2 Financial performance
10.6.16.3 Product benchmarking
10.6.16.4 Strategic initiatives
10.6.17 New England Biolabs
10.6.17.1 Company overview
10.6.17.2 Financial performance
10.6.17.3 Product benchmarking
10.6.17.4 Strategic initiatives
10.6.18 OriGene Technologies, Inc.
10.6.18.1 Company overview
10.6.18.2 Financial performance
10.6.18.3 Product benchmarking
10.6.18.4 Strategic initiatives
10.6.19 bluebird bio, Inc.
10.6.19.1 Company overview
10.6.19.2 Financial performance
10.6.19.3 Product benchmarking
10.6.19.4 Strategic initiatives
10.6.20 Lonza
10.6.20.1 Company overview
10.6.20.2 Financial performance
10.6.20.3 Product benchmarking
10.6.20.4 Strategic initiatives
10.6.21 Thermo Fisher Scientific, Inc.
10.6.21.1 Company overview
10.6.21.2 Financial performance
10.6.21.3 Product benchmarking
10.6.21.4 Strategic initiatives

List of Tables

TABLE 1 Genome editing technology comparison
TABLE 2 North America genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 3 North America genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 4 North America genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 5 North America genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 6 North America genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 7 North America genome editing market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 8 North America genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 9 U.S. genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 10 U.S.genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 11 U.S.genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 12 U.S. genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 13 U.S. genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 14 U.S.genome editing market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 15 U.S.genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 16 Canada genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 17 Canada genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 18 Canada genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 19 Canada genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 20 Canada genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 21 Canada genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 22 Canada genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 23 Europe genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 24 Europe genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 25 Europe genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 26 Europe genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 27 Europe genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 28 Europe genome editing market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 29 Europe genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 30 Germany genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 31 Germany genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 32 Germany genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 33 Germany genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 34 Germany genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 35 Germany genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 36 Germany genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 37 U.K. genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 38 U.K. genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 39 U.K. genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 40 U.K. genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 41 U.K. genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 42 U.K. genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 43 U.K. genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 44 France genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 45 France genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 46 France genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 47 France genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 48 France genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 49 France genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 50 France genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 51 Italy genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 52 Italy genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 53 Italy genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 54 Italy genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 55 Italy genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 56 Italy genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 57 Italy genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 58 Spain genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 59 Spain genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 60 Spain genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 61 Spain genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 62 Spain genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 63 Spain genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 64 Spain genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 65 Asia Pacific genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 66 Asia Pacific genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 67 Asia Pacific genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 68 Asia Pacific genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 69 Asia Pacific genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 70 Asia Pacific genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 71 Asia Pacific genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 72 Japan genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 73 Japan genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 74 Japan genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 75 Japan genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 76 Japan genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 77 Japan genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 78 Japan genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 79 China genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 80 China genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 81 China genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 82 China genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 83 China genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 84 China genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 85 China genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 86 South Korea genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 87 South Korea genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 88 South Korea genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 89 South Korea genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 90 South Korea genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 91 South Korea genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 92 South Korea genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 93 India genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 94 India genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 95 India genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 96 India genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 97 India genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 99 India genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 100 India genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 101 Latin America genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 102 Latin America genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 103 Latin America genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 104 Latin America genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 105 Latin America genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 106 Latin America genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 107 Latin America genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 108 Brazil genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 109 Brazil genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 110 Brazil genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 111 Brazil genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 112 Brazil genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 113 Brazil genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 114 Brazil genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 115 Mexico genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 116 Mexico genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 117 Mexico genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 118 Mexico genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 119 Mexico genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 120 Mexico genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 121 Mexico genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 122 MEA genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 123 MEA genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 124 MEA genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 125 MEA genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 126 MEA genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 127 MEA genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 128 MEA genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 129 South Africa genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 130 South Africa genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 131 South Africa genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 132 South Africa genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 133 South Africa genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 134 South Africa genome editing market estimates & forecasts, by end use, 2017 - 2028 (USD Million)
TABLE 135 South Africa genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)
TABLE 136 Saudi Arabia genome editing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 137 Saudi Arabia genome editing market estimates & forecasts, by delivery method, 2017 - 2028 (USD Million)
TABLE 138 Saudi Arabia genome editing market estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 139 Saudi Arabia genome editing market for genetic engineering estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 140 Saudi Arabia genome editing market for clinical applications estimates & forecasts, by application, 2017 - 2028 (USD Million)
TABLE 141 Saudi Arabia genome editing market estimates & forecasts, by end use,2017 - 2028 (USD Million)
TABLE 142 Saudi Arabia genome editing market estimates & forecasts, by mode, 2017 - 2028 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Applications of genome editing in therapeutic models
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping for technology, 2020
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 genome editing market: Technology outlook key takeaways
FIG. 17 genome editing market: Technology movement analysis
FIG. 18 Global (CRISPR)/Cas9market, 2017 - 2028 (USD Million)
FIG. 19 Global TALENs/MegaTALs market, 2017 - 2028 (USD Million)
FIG. 20 Global ZFN market, 2017 - 2028 (USD Million)
FIG. 21 Global meganucleases market, 2017 - 2028 (USD Million)
FIG. 22 Global other technologies market, 2017 - 2028 (USD Million)
FIG. 23 genome editing market: Delivery method outlook key takeaways
FIG. 24 genome editing market: Delivery method movement analysis
FIG. 25 Global ex-vivo delivery market, 2017 - 2028 (USD Million)
FIG. 26 Global in-vivo delivery market, 2017 - 2028 (USD Million)
FIG. 27 genome editing market: Application outlook key takeaways
FIG. 28 Global genome editing market: Application movement analysis
FIG. 29 Global genetic engineering market, 2017 - 2028 (USD Million)
FIG. 30 Global cell line engineering / gene therapy market, 2017 - 2028 (USD Million)
FIG. 31 Global animal genetic engineering market, 2017 - 2028 (USD Million)
FIG. 32 Global plant genetic engineering market, 2017 - 2028 (USD Million)
FIG. 33 Global other applications market, 2017 - 2028 (USD Million)
FIG. 34 Global clinical applications market, 2017 - 2028 (USD Million)
FIG. 35 Global diagnostic applications market, 2017 - 2028 (USD Million)
FIG. 36 Global therapy development applications market, 2017 - 2028 (USD Million)
FIG. 37 genome editing market: End-use outlook key takeaways
FIG. 38 Global genome editing market: End-use movement analysis
FIG. 39 Global biotechnology & pharmaceutical companies market, 2017 - 2028 (USD Million)
FIG. 40 Global academic & government research institutes market, 2017 - 2028 (USD Million)
FIG. 41 Global CROs market, 2017 - 2028 (USD Million)
FIG. 42 genome editing market: Mode outlook key takeaways
FIG. 43 Global genome editing market: Mode movement analysis
FIG. 44 Global in-house gene editing market, 2017 - 2028 (USD Million)
FIG. 45 Global contract gene editing market, 2017 - 2028 (USD Million)
FIG. 46 Regional market place: Key takeaway
FIG. 47 Genome editing regional outlook, 2020 & 2028
FIG. 48 North America genome editing market, 2017 - 2028 (USD Million)
FIG. 49 U.S. genome editing market, 2017 - 2028 (USD Million)
FIG. 50 Canada genome editing market, 2017 - 2028 (USD Million)
FIG. 51 Europe genome editing market, 2017 - 2028 (USD Million)
FIG. 52 Germany genome editing market, 2017 - 2028 (USD Million)
FIG. 53 U.K. genome editing market, 2017 - 2028 (USD Million)
FIG. 54 France genome editing market, 2017 - 2028 (USD Million)
FIG. 55 Italy genome editing market, 2017 - 2028 (USD Million)
FIG. 56 Spain genome editing market, 2017 - 2028 (USD Million)
FIG. 57 Asia Pacific genome editing market, 2017 - 2028 (USD Million)
FIG. 58 Japan genome editing market, 2017 - 2028 (USD Million)
FIG. 59 China genome editing market, 2017 - 2028 (USD Million)
FIG. 60 South Korea genome editing market, 2017 - 2028 (USD Million)
FIG. 61 India genome editing market, 2017 - 2028 (USD Million)
FIG. 62 Latin America genome editing market, 2017 - 2028 (USD Million)
FIG. 63 Brazil genome editing market, 2017 - 2028 (USD Million)
FIG. 64 Mexico genome editing market, 2017 - 2028 (USD Million)
FIG. 65 Middle East & Africa genome editing market, 2017 - 2028 (USD Million)
FIG. 66 South Africa genome editing market, 2017 - 2028 (USD Million)
FIG. 67 Saudi Arabia genome editing market, 2017 - 2028 (USD Million)
FIG. 68 Strategy framework
FIG. 69 Participant categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のゲノム編集市場2021-2028:技術別(CRISPR、ZFN、TALEN)、送達方法別、用途別、モード別、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆